ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
22.461,52
-0,89%
S&P 500
5.578,60
-2,01%
Dow Jones
41.563,52
-1,74%
Euro vs US Dollar
1,08219
0,19%
Bitcoin
83.567,71
-4,16%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Context Therapeutics Inc (CNTX)

  7. Context Therapeutics Inc (CNTX) News

CNTX

Context Therapeutics (CNTX)

Context Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CNTX
DatumZeitQuelleÜberschriftSymbolFirma
26/03/202521h02GlobeNewswire Inc.Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2025NASDAQ:CNTXContext Therapeutics Inc
20/03/202521h44Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CNTXContext Therapeutics Inc
20/03/202521h22GlobeNewswire Inc.Context Therapeutics Reports Full Year 2024 Operating and Financial ResultsNASDAQ:CNTXContext Therapeutics Inc
20/03/202521h15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CNTXContext Therapeutics Inc
28/02/202522h06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CNTXContext Therapeutics Inc
24/02/202523h05GlobeNewswire Inc.Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:CNTXContext Therapeutics Inc
19/02/202513h30GlobeNewswire Inc.Context Therapeutics to Participate in Upcoming Investor ConferencesNASDAQ:CNTXContext Therapeutics Inc
14/02/202523h09Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CNTXContext Therapeutics Inc
14/02/202522h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CNTXContext Therapeutics Inc
14/02/202522h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CNTXContext Therapeutics Inc
14/02/202522h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CNTXContext Therapeutics Inc
14/02/202522h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CNTXContext Therapeutics Inc
14/02/202512h27Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CNTXContext Therapeutics Inc
12/02/202523h20Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CNTXContext Therapeutics Inc
14/01/202523h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CNTXContext Therapeutics Inc
14/01/202522h58GlobeNewswire Inc.Context Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of CTIM-76NASDAQ:CNTXContext Therapeutics Inc
13/01/202513h37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CNTXContext Therapeutics Inc
13/01/202513h30GlobeNewswire Inc.Context Therapeutics Appoints Andy Pasternak as Chairman of the Board of DirectorsNASDAQ:CNTXContext Therapeutics Inc
23/12/202415h26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CNTXContext Therapeutics Inc
02/12/202422h21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CNTXContext Therapeutics Inc
02/12/202422h20Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CNTXContext Therapeutics Inc
15/11/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CNTXContext Therapeutics Inc
14/11/202423h05Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:CNTXContext Therapeutics Inc
06/11/202422h42Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CNTXContext Therapeutics Inc
06/11/202422h06GlobeNewswire Inc.Context Therapeutics Reports Third Quarter 2024 Operating and Financial ResultsNASDAQ:CNTXContext Therapeutics Inc
06/11/202422h02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CNTXContext Therapeutics Inc
23/10/202413h30GlobeNewswire Inc.Context Therapeutics to Participate in Upcoming Investor Conferences in NovemberNASDAQ:CNTXContext Therapeutics Inc
16/10/202413h30GlobeNewswire Inc.Context Therapeutics Announces Poster Presentation at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual MeetingNASDAQ:CNTXContext Therapeutics Inc
23/09/202413h33Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CNTXContext Therapeutics Inc
17/09/202422h22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CNTXContext Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CNTX

Kürzlich von Ihnen besucht

COIN
ANGLEUST
ANGLE
Delayed Upgrade Clock
ADVFN Logo
Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten